MedX Health Corp. Announces Its Third Quarter 2015 Financial Results and...
MISSISSAUGA, ON--(Marketwired - November 27, 2015) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) announced its results for the three and nine months ended September 30, 2015, which...
View ArticleOutcomes Study Reports Use of MelaFind Reduced Benign Biopsies by 61% in...
(Source: MELA Sciences Inc) For Immediate Release Outcomes Study Reports Use of MelaFind Reduced Benign Biopsies by 61% in Patients at Risk for Melanoma Irvington, NY,October 21, 2014- MELA Sciences,...
View ArticleMELA Sciences Participates in the American Society of Dermatologic Surgery...
(Source: MELA Sciences Inc) IRVINGTON, N.Y., October 2, 2013 - MELA Sciences, Inc. (NASDAQ: MELA), the medical device company that developed and is commercializing MelaFind®, the first and only...
View ArticleMELA Sciences Initiates First Study to Investigate Real-World Clinical Impact...
IRVINGTON, N.Y., June 3, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the United States and the...
View ArticleMELA Sciences Reports Positive Reception for its Optical Melanoma Diagnostic...
(Source: MELA Sciences Inc) MELA Sciences Reports Positive Reception for its Optical Melanoma Diagnostic Device at Clinical Advisory Meeting and Mount Sinai Winter Dermatology Symposium New York, NY...
View ArticleMELA Sciences, Inc. to Participate in the Fall Clinical Dermatology...
(Source: MELA Sciences Inc) Leading Dermatologists to Present Clinical Findings in Four Poster Presentations at the 32nd Annual Fall Clinical Dermatology Conference in Las Vegas, Nevada IRVINGTON,...
View ArticleMELA Sciences, Inc., a Leader in the Fight Against Melanoma, Participates in...
My news for Investors AtLeast one of the check box should be selected You are following news about Follow the latest news about MELA Download image MELA Sciences. (PRNewsFoto/MELA Sciences, Inc.)...
View ArticleMELA Sciences Reports Third Quarter 2014 Financial Results
Conference Call Today at 4:30 p.m. Eastern Time IRVINGTON, N.Y., Nov. 12, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, a non-invasive software-driven...
View ArticleMelanoma Diagnostics Leader, MELA Sciences, Hosts Clinical Advisory Meeting...
(Source: MELA Sciences Inc) New York, NY & Irvington, NY December 5, 2013 - MELA Sciences, Inc. (NASDAQ: MELA) designer and developer of MelaFind®, an FDA approved non-invasive optical device that...
View ArticleMELA Sciences, Inc. to Participate in the Fall Clinical Dermatology Conference
IRVINGTON, N.Y., Oct. 16, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind®, the first and only FDA approved...
View ArticleMELA Sciences Reports Positive Reception for its Optical Melanoma Diagnostic...
MELA Sciences, Inc. (NASDAQ: MELA) designer and developer of MelaFind®, an FDA approved non-invasive optical device that assists dermatologists in the diagnosis of melanoma, received positive...
View ArticleMELA Sciences Reports Positive Reception for its Optical Melanoma Diagnostic...
NEW YORK & IRVINGTON, N.Y.--(BUSINESS WIRE)--MELA Sciences, Inc. (NASDAQ: MELA) designer and developer of MelaFind®, an FDA approved non-invasive optical device that assists dermatologists in the...
View ArticleDermatologist Highlights Medical Benefits of MelaFind Device in Aiding...
MAUI, Hawaii & IRVINGTON, N.Y.--(BUSINESS WIRE)--MELA Sciences, Inc. (NASDAQ: MELA), developer of MelaFind®, an FDA approved optical diagnostic device that assists dermatologists in the diagnosis...
View ArticleMelanoma Diagnostics Leader, MELA Sciences, Hosts Clinical Advisory Meeting...
MELA Sciences, Inc. (NASDAQ:MELA) designer and developer of MelaFind®, an FDA approved non-invasive optical device that assists dermatologists in diagnosing melanoma at its most curable stage,...
View ArticleMELA Sciences Announces New Study Results Demonstrating Improved Diagnostic...
IRVINGTON, N.Y., July 24, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European Union...
View ArticleMelanoma Diagnostics Leader, MELA Sciences, Hosts Clinical Advisory Meeting...
NEW YORK & IRVINGTON, N.Y.--(BUSINESS WIRE)--MELA Sciences, Inc. (NASDAQ:MELA) designer and developer of MelaFind®, an FDA approved non-invasive optical device that assists dermatologists in...
View ArticleNew Data Presented at the Fall Clinical Dermatology Conference Supports...
(Source: MELA Sciences Inc) IRVINGTON, N.Y., Oct. 21, 2013 (GLOBE NEWSWIRE) - MELA Sciences, Inc. (MELA), a leader in the fight against melanoma with MelaFind®, the first and only FDA approved optical...
View ArticleVerisante Technology, Inc. Welcomes Dr. Kenneth Beer and Dr. Philip Werschler...
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jul 29, 2014) - Verisante Technology, Inc. (TSX VENTURE:VRS)(OTCQX:VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, is pleased...
View ArticleMedX Health Corp. Results for the Third Quarter of Fiscal 2013
TSX Venture Symbol: MDX CUSIP #: 585090 MISSISSAUGA, ON, Nov. 12, 2013 /CNW/ - MedX Health Corp. ("MDX" or the "Company") (TSX-V: MDX) reported today its financial and operational results for the Third...
View ArticleMedX Health Corp. Announces Extension of Private Placement
MISSISSAUGA, ONTARIO--(Marketwired - April 14, 2014) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE:MDX) announces that it has extended, to April 30, 2014, the date for closing of a further...
View ArticleMedX Health Corp. Announces Extension of Private Placement (MedX Health Corp)
(Source: MedX Health Corp) MISSISSAUGA, ONTARIO-( April 14, 2014) -MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE:MDX) announces that it has extended, to April 30, 2014, the date for closing...
View ArticleMedX Health Corp. Announces Closing of Second Tranche of Private Placement
MISSISSAUGA, ONTARIO--(Marketwired - May 9, 2014) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE:MDX) announces that it has closed on a second tranche of a private placement, as previously...
View ArticleMedX Health Corp. Announces Closing of Second Tranche of Private Placement...
(Source: MedX Health Corp) Mississauga, ON, May 9, 2014 - MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) announces that it has closed on a second tranche of a private placement, as previously...
View ArticleMedX Health Corp. Announces Proposed Debt Settlements and Private Placement
MISSISSAUGA, ON, Oct. 29, 2013 /CNW/ - MedX Health Corp. (TSX-V - MDX), announces that it has entered into agreements to settle a total of $1,779,933 of debt owed to certain trade creditors, general...
View ArticleMedX Health Corp. Announces Year End Financial Results (MedX Health Corp)
(Source: MedX Health Corp) Mississauga, ON, April 30, 2014 - MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) announced its results for the year ended December 31, 2013, which are also...
View ArticleMedX Health Announces a Pharmacy Pilot in Sweden and Distribution Agreement...
MISSISSAUGA, ON--(Marketwired - February 05, 2015) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX), dedicated to the early detection of skin cancer, gave an update on recent business...
View ArticleMedX Health Corp. Announces Approval of Debt Settlement and AGM Results
MISSISSAUGA, ONTARIO--(Marketwired - June 25, 2014) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE:MDX) announces that at its Annual and Special Meeting of Shareholders held on June 24,...
View ArticleMedX Health Corp. Announces $500,000 Debt Financing (MedX Health Corp)
(Source: MedX Health Corp) FOR IMMEDIATE RELEASE TSX Venture Exchange: MDX MedX Health Corp. Announces $500,000 Debt Financing Mississauga, ON, July 15, 2015 - MedX Health Corp. ("MedX" or the...
View ArticleMedX Health Corp. Announces Approval of Debt Settlement and AGM Results (MedX...
(Source: MedX Health Corp) Mississauga, ON, June 25, 2014 - MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) announces that at its Annual and Special Meeting of Shareholders held on June 24,...
View ArticleMedX Health Corp. Announces $500,000 Debt Financing
MISSISSAUGA, ON--(Marketwired - July 15, 2015) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) announced that it has completed a $500,000 term loan with a party related to a Director...
View ArticleMedX Health Corp. Selected by BodyCheck NL to Supply Its SIAscopy(TM) Skin...
MISSISSAUGA, ON--(Marketwired - October 05, 2015) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX), a leading medical device company, announced it has completed an agreement to become...
View ArticleMedX Health Corp. Announces Pharmacy Pilot in the United Kingdom (MedX Health...
(Source: MedX Health Corp) FOR IMMEDIATE RELEASE TSX Venture Exchange: MDX MedX Health Corp. Announces Pharmacy Pilot in the United Kingdom Mississauga, ON, July 6, 2015 - MedX Health Corp. ("MedX" or...
View ArticleMedX Health Corp. Announces Pharmacy Pilot in the United Kingdom
MISSISSAUGA, ON--(Marketwired - July 06, 2015) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) gave an update on recent business developments today, announcing that its European...
View ArticleMedX Health Corp. Announces First Quarter 2014 Financial Results
MISSISSAUGA, ONTARIO--(Marketwired - May 29, 2014) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE:MDX) announced its results for the three months ended March 31, 2014, which are also...
View ArticleMedX Health Corp. Announces Second Quarter 2014 Financial Results
MISSISSAUGA, ONTARIO--(Marketwired - Aug. 27, 2014) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE:MDX), dedicated to the early detection of skin cancer, announced its results for the three...
View Article?MedX Health Corp. Announces Second Quarter 2014 Financial Results (MedX...
(Source: MedX Health Corp) Mississauga, ON, August 27, 2014 - MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX), dedicated to the early detection of skin cancer, announced its results for the...
View ArticleMedX Health Corp. Announces First Quarter 2014 Financial Results (MedX Health...
(Source: MedX Health Corp) Mississauga, ON, May 29, 2014 - MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) announced its results for the three months ended March 31, 2014, which are also...
View ArticleMedX Health Corp. Announces a 51% Increase in Sales in Its 2014 Year End...
MISSISSAUGA, ON--(Marketwired - April 29, 2015) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) announced its results for the year ended December 31, 2014, which are also available on...
View ArticleMedX Health Corp. Announces a 67% Revenue Increase in Its Second Quarter 2015...
MISSISSAUGA, ON--(Marketwired - August 28, 2015) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) announced its results for the three and six months ended June 30, 2015, which are also...
View ArticleMedX Health Corp. Announces Third Quarter 2014 Financial Results and the...
MISSISSAUGA, ONTARIO--(Marketwired - Nov. 26, 2014) - NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES MedX Health Corp. ("MedX" or the "Company") (TSX...
View ArticleMedX Health Corp. Announces Issuance of Shares and Share Option Grant
MISSISSAUGA, ON--(Marketwired - December 31, 2015) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) announces that, effective December 23, 2015, it has issued 3,253,437 common shares in...
View ArticleMedX Health Corp. Closes 2015 With Positive Sales and Eliminates 10% Royalty...
MISSISSAUGA, ON--(Marketwired - January 07, 2016) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX), a leading medical device company, announced it has completed a transaction that...
View ArticleMelanoma Diagnostics Leader, MELA Sciences, Inc., Participates in Skin Cancer...
AUGSBURG, Germany & IRVINGTON, N.Y.--(BUSINESS WIRE)--MELA Sciences, Inc. (NASDAQ:MELA), designer and developer of MelaFind®, an FDA and CE Mark approved non-invasive optical device that assists...
View ArticleMELA Sciences, Inc., a Leader in the Fight Against Melanoma, Participates in...
IRVINGTON, N.Y., Oct. 25, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind®, the first and only FDA approved...
View ArticleCell MedX Corp. Introduces Ongoing eBalance Pro Trial Observations Online
LAS VEGAS, NV--(Marketwired - Jan 25, 2016) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a development stage company focused on the commercialization of therapeutic devices for...
View ArticleMedX Health Corp. Expands Capability in Europe
MISSISSAUGA, ON--(Marketwired - February 24, 2016) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX), a leading medical device company, is expanding its growth capacity with the addition...
View ArticleNeuroMetrix Reports Q3 2013 Results
Progress in Building Broad Distribution Channel for SENSUS" Pain Management System WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (the Company) (Nasdaq: NURO), a medical device company focused on...
View ArticleShedding light on skin cancer
Adevice invented at the BC Cancer Agency offers a non-invasive, painless, instantaneous opinion on whether skin lesions are cancerous or not. After 15 years of research and development, it's finally...
View ArticleCell MedX Corp. (CMXC) Engages Nutrasource Diagnostics Inc. to Commence...
LAS VEGAS, NV--(Marketwired - Mar 22, 2016) - Cell MedX Corp. (OTCQB: CMXC), ("Cell MedX" or the "Company") is pleased to announce that it has engaged Nutrasource Diagnostics Inc. ("NDI") to commence...
View ArticleMELA Sciences, Inc. a Leader in the Fight Against Melanoma, Exhibiting...
IRVINGTON, N.Y., Sept. 25, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind®, the first and only FDA approved...
View Article